Incidental Finding of a Balanced Translocation in a Gamete Donor
A couple undergoing IVF with an anonymous oocyte donor learns that the donor's expanded carrier screening was negative, but the donor's clinic reports that a routine karyotype performed for another reason showed 46,XX,t(11;22)(q23;q11.2). The donor is reported to be healthy with no history of recurrent pregnancy loss. The recipient couple has had two prior first-trimester miscarriages with the wife's own oocytes, and the wife is 40. The couple asks whether the donor's translocation matters and whether they should switch donors.
1. What is the significance of the donor's t(11;22)(q23;q11.2)?
Read the worked answer
This is the classic recurrent constitutional translocation, t(11;22)(q23;q11.2), which is the most common reciprocal translocation in humans. Carriers are typically phenotypically normal but are at increased risk of producing unbalanced gametes. The relevant concern is offspring with der(22)t(11;22) - the Emanuel syndrome chromosome - which causes severe intellectual disability, hypotonia, cardiac and other anomalies. The risk of an unbalanced liveborn is low but not negligible; the more common outcome of unbalanced conceptions is miscarriage.
The donor being healthy and without pregnancy loss history is consistent with a balanced carrier. The finding is relevant to the couple because the donor's gametes may carry unbalanced chromosome complements.
2. How should the couple be counseled about donor selection and testing options?
Read the worked answer
Options include:
- Switch to a different donor (simplest way to eliminate the risk).
- Continue with this donor and use preimplantation genetic testing for structural rearrangements (PGT-SR) to select embryos with balanced or normal chromosome complements. PGT-SR requires a validated probe set for this specific translocation and is feasible at experienced centers.
- If PGT-SR is not available, prenatal diagnosis (CVS or amniocentesis with karyotype) can detect unbalanced offspring, but this does not prevent miscarriage.
The counseling should be balanced: the absolute risk of an affected liveborn is low, but the couple's prior miscarriages (though with the wife's own oocytes) may heighten anxiety. The decision is values-based; the counselor should present the options without steering. Also note that the donor's carrier screening being negative does not address structural rearrangements.
3. The couple asks whether the wife's prior miscarriages could be related to the donor. What is the correct response?
Read the worked answer
No - the prior miscarriages occurred with the wife's own oocytes, so they cannot be attributed to the donor's translocation. They should be evaluated on their own merits (maternal age 40, possible aneuploidy, uterine or thrombophilic factors).
However, the wife's history of recurrent loss is a separate indication for evaluation and may influence the couple's decision-making and the IVF plan (e.g., PGT-A consideration, though its role is debated). The counselor should avoid conflating the two issues and should clarify that the donor finding is a new, independent consideration.
The judgment: not allowing the salient donor finding to distract from the wife's own clinical evaluation.